{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2025:7QB57U2ZR7D3NNBNFHJJYSEDIG","short_pith_number":"pith:7QB57U2Z","schema_version":"1.0","canonical_sha256":"fc03dfd3598fc7b6b42d29d29c488341934d9173e89e70bdc54c34b7293b5a92","source":{"kind":"arxiv","id":"2501.14097","version":3},"attestation_state":"computed","paper":{"title":"Assessing treatment efficacy for interval-censored endpoints using multistate semi-Markov models fit to multiple data streams","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":["stat.AP"],"primary_cat":"stat.ME","authors_text":"Allyson Mateja, Chenguang Wang, C. Jason Liang, Dean A. Follmann, Jonathan Fintzi, Meagan P. O'Brien, Raphael Morsomme","submitted_at":"2025-01-23T21:08:59Z","abstract_excerpt":"We introduce a computationally efficient and general approach for utilizing multiple, possibly interval-censored, data streams to study complex biomedical endpoints using multistate semi-Markov models. Our motivating application is the REGEN-2069 trial, which investigated the protective efficacy (PE) of the monoclonal antibody combination REGEN-COV against SARS-CoV-2 when administered prophylactically to individuals in households at high risk of secondary transmission. Using data on symptom onset, episodic RT-qPCR sampling, and serological testing, we estimate the PE of REGEN-COV for asymptoma"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"2501.14097","kind":"arxiv","version":3},"metadata":{"license":"http://creativecommons.org/licenses/by/4.0/","primary_cat":"stat.ME","submitted_at":"2025-01-23T21:08:59Z","cross_cats_sorted":["stat.AP"],"title_canon_sha256":"ffd4b7984d4933b1e4312347c6d3f4c13f896e9bf2fdcc452731dd2f5b7ef320","abstract_canon_sha256":"21aeb479f9a4e77ba5fa656c512d0befc979ea9194e074bfd8f0b9901dc41d77"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T11:34:03.904606Z","signature_b64":"lh1fLVpfOqaZIbLJ2GwKD4zeO5EwZv4KP8wmFO+mj/dPs+iY3m9aolywQnQjjUqdrCoxjzR/U+3dWRUHIv0EBA==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"fc03dfd3598fc7b6b42d29d29c488341934d9173e89e70bdc54c34b7293b5a92","last_reissued_at":"2026-07-05T11:34:03.904115Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T11:34:03.904115Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"Assessing treatment efficacy for interval-censored endpoints using multistate semi-Markov models fit to multiple data streams","license":"http://creativecommons.org/licenses/by/4.0/","headline":"","cross_cats":["stat.AP"],"primary_cat":"stat.ME","authors_text":"Allyson Mateja, Chenguang Wang, C. Jason Liang, Dean A. Follmann, Jonathan Fintzi, Meagan P. O'Brien, Raphael Morsomme","submitted_at":"2025-01-23T21:08:59Z","abstract_excerpt":"We introduce a computationally efficient and general approach for utilizing multiple, possibly interval-censored, data streams to study complex biomedical endpoints using multistate semi-Markov models. Our motivating application is the REGEN-2069 trial, which investigated the protective efficacy (PE) of the monoclonal antibody combination REGEN-COV against SARS-CoV-2 when administered prophylactically to individuals in households at high risk of secondary transmission. Using data on symptom onset, episodic RT-qPCR sampling, and serological testing, we estimate the PE of REGEN-COV for asymptoma"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2501.14097","kind":"arxiv","version":3},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2501.14097/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"2501.14097","created_at":"2026-07-05T11:34:03.904177+00:00"},{"alias_kind":"arxiv_version","alias_value":"2501.14097v3","created_at":"2026-07-05T11:34:03.904177+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2501.14097","created_at":"2026-07-05T11:34:03.904177+00:00"},{"alias_kind":"pith_short_12","alias_value":"7QB57U2ZR7D3","created_at":"2026-07-05T11:34:03.904177+00:00"},{"alias_kind":"pith_short_16","alias_value":"7QB57U2ZR7D3NNBN","created_at":"2026-07-05T11:34:03.904177+00:00"},{"alias_kind":"pith_short_8","alias_value":"7QB57U2Z","created_at":"2026-07-05T11:34:03.904177+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":1,"internal_anchor_count":1,"sample":[{"citing_arxiv_id":"2502.03479","citing_title":"Markov Renewal Proportional Hazards is All You Need","ref_index":50,"is_internal_anchor":true}]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/7QB57U2ZR7D3NNBNFHJJYSEDIG","json":"https://pith.science/pith/7QB57U2ZR7D3NNBNFHJJYSEDIG.json","graph_json":"https://pith.science/api/pith-number/7QB57U2ZR7D3NNBNFHJJYSEDIG/graph.json","events_json":"https://pith.science/api/pith-number/7QB57U2ZR7D3NNBNFHJJYSEDIG/events.json","paper":"https://pith.science/paper/7QB57U2Z"},"agent_actions":{"view_html":"https://pith.science/pith/7QB57U2ZR7D3NNBNFHJJYSEDIG","download_json":"https://pith.science/pith/7QB57U2ZR7D3NNBNFHJJYSEDIG.json","view_paper":"https://pith.science/paper/7QB57U2Z","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=2501.14097&json=true","fetch_graph":"https://pith.science/api/pith-number/7QB57U2ZR7D3NNBNFHJJYSEDIG/graph.json","fetch_events":"https://pith.science/api/pith-number/7QB57U2ZR7D3NNBNFHJJYSEDIG/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/7QB57U2ZR7D3NNBNFHJJYSEDIG/action/timestamp_anchor","attest_storage":"https://pith.science/pith/7QB57U2ZR7D3NNBNFHJJYSEDIG/action/storage_attestation","attest_author":"https://pith.science/pith/7QB57U2ZR7D3NNBNFHJJYSEDIG/action/author_attestation","sign_citation":"https://pith.science/pith/7QB57U2ZR7D3NNBNFHJJYSEDIG/action/citation_signature","submit_replication":"https://pith.science/pith/7QB57U2ZR7D3NNBNFHJJYSEDIG/action/replication_record"}},"created_at":"2026-07-05T11:34:03.904177+00:00","updated_at":"2026-07-05T11:34:03.904177+00:00"}